Elliott Management disclosed a stake in Air Liquide valued at approximately €3.0 billion ($3.2 billion) on Monday, immediately pressing the €80 billion market-cap French industrial-gas supplier to narrow a persistent margin gap against sector leader Linde. The move marks Elliott's largest European activism play since its €2.5 billion SAP campaign concluded in 2023, and the first time a U.S. activist has targeted the 123-year-old Paris-listed incumbent with a formal operational critique.
Air Liquide reported trailing-twelve-month EBITDA margin of 21.4% in its most recent quarterly filing, lagging Linde's 28.2% and Air Products' 26.1%. Elliott's presentation to the board—delivered through London-based partner James Smith—identifies €1.8 billion in annual run-rate savings by 2027 through three levers: portfolio rationalization of non-core healthcare assets representing 14% of revenue, procurement centralization across seventeen country subsidiaries, and operational-excellence programs at twenty-three underperforming hydrogen production sites. The firm calculates that closing two-thirds of the margin delta would lift Air Liquide's enterprise value by €22 billion, or 27%, absent multiple expansion. Elliott is not seeking a board seat immediately but has proposed two independent directors with Linde and Praxair operating experience for the May 2025 annual meeting.
The stakes are structural. Air Liquide dominates European merchant gas and medical oxygen but carries legacy cost structures from acquisitions that predate the Linde-Praxair merger of 2018. Linde, now domiciled in Ireland and managed from Connecticut, operates a global shared-services model that Air Liquide has resisted in favor of country-level autonomy. Elliott's thesis is that the autonomy premium—defended by management as customer intimacy—costs 680 basis points in margin and no longer delivers revenue growth advantage; Air Liquide's three-year organic growth rate is 4.2%, identical to Linde's. The activist is privately circulating a forty-two-page deck showing that Air Liquide's return on invested capital has compressed from 9.8% in 2019 to 8.1% in 2024, while Linde's has expanded from 10.4% to 12.6% over the same span. That ROIC spread matters acutely to long-duration infrastructure allocators, who represent 38% of Air Liquide's shareholder base and have begun asking the same questions.
Operators and allocators should track three near-term events. First, Air Liquide's March 12 full-year earnings call, where management will address margin trajectory for the first time under activist pressure. Second, any announced portfolio reviews of the Seppic specialty-ingredients unit or the Advanced Technologies division, both cited in Elliott's initial outreach as divestiture candidates worth a combined €4.2 billion. Third, proxy filings ahead of the May shareholder meeting, which will reveal whether Elliott escalates to a formal board nomination or secures private commitments on operational targets. Activist campaigns at European industrials typically resolve in twelve to eighteen months; Elliott's SAP engagement produced €3.1 billion in cost actions and a CEO transition in sixteen months.
Air Liquide's shares closed Monday at €172.40, up 3.8% on the disclosure, implying the market prices in roughly one-third of Elliott's value-creation case. The company has not yet filed a 13D equivalent under French disclosure rules, suggesting the stake may sit just below the 5% threshold requiring public notice. Elliott's last industrial-gas activism—a 2019 campaign at Air Products that ended with a negotiated cost program—delivered 41% absolute returns over two years. The margin gap with Linde is now wider than it was then.